These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10554538)

  • 21. Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis.
    Zheng M; Bai J; Yuan B; Lin F; You J; Lu M; Gong Y; Chen Y
    BMC Gastroenterol; 2008 Feb; 8():6. PubMed ID: 18271973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial.
    Concepción-Martín M; Gómez-Oliva C; Juanes A; Díez X; Prieto-Alhambra D; Torras X; Sainz S; Villanueva C; Farre A; Guarner-Argente C; Guarner C
    Endoscopy; 2014 Oct; 46(10):851-6. PubMed ID: 24977398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of the administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes].
    Montaño Loza A; Rodríguez Lomelí X; García Correa JE; Dávalos Cobián C; Cervantes Guevara G; Medrano Muñoz F; Fuentes Orozco C; González Ojeda A
    Rev Esp Enferm Dig; 2007 Jun; 99(6):330-6. PubMed ID: 17883296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis.
    Budzyńska A; Marek T; Nowak A; Kaczor R; Nowakowska-Dulawa E
    Endoscopy; 2001 Sep; 33(9):766-72. PubMed ID: 11558030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggressive hydration with lactated Ringer's solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography.
    Buxbaum J; Yan A; Yeh K; Lane C; Nguyen N; Laine L
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):303-7.e1. PubMed ID: 23920031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antioxidant supplementation for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Gu WJ; Wei CY; Yin RX
    Nutr J; 2013 Feb; 12():23. PubMed ID: 23398675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial.
    Sperna Weiland CJ; Smeets XJNM; Kievit W; Verdonk RC; Poen AC; Bhalla A; Venneman NG; Witteman BJM; da Costa DW; van Eijck BC; Schwartz MP; Römkens TEH; Vrolijk JM; Hadithi M; Voorburg AMCJ; Baak LC; Thijs WJ; van Wanrooij RL; Tan ACITL; Seerden TCJ; Keulemans YCA; de Wijkerslooth TR; van de Vrie W; van der Schaar P; van Dijk SM; Hallensleben NDL; Sperna Weiland RL; Timmerhuis HC; Umans DS; van Hooft JE; van Goor H; van Santvoort HC; Besselink MG; Bruno MJ; Fockens P; Drenth JPH; van Geenen EJM;
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):350-358. PubMed ID: 33740415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
    Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
    BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antioxidant drugs to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: What does evidence suggest?
    Fuentes-Orozco C; Dávalos-Cobián C; García-Correa J; Ambriz-González G; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Chávez-Tostado M; Cuesta-Márquez LA; Alvarez-Villaseñor AS; Cortés-Flores AO; González-Ojeda A
    World J Gastroenterol; 2015 Jun; 21(21):6745-53. PubMed ID: 26074713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
    Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
    Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography.
    Brand M; Bizos D; O'Farrell P
    Cochrane Database Syst Rev; 2010 Oct; (10):CD007345. PubMed ID: 20927758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early sequential changes in serum markers of acute pancreatitis induced by endoscopic retrograde cholangiopancreatography.
    Lempinen M; Stenman UH; Halttunen J; Puolakkainen P; Haapiainen R; Kemppainen E
    Pancreatology; 2005; 5(2-3):157-64. PubMed ID: 15849486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis.
    Rabenstein T; Fischer B; Wiessner V; Schmidt H; Radespiel-Tröger M; Hochberger J; Mühldorfer S; Nusko G; Messmann H; Schölmerich J; Schulz HJ; Schönekäs H; Hahn EG; Schneider HT
    Gastrointest Endosc; 2004 May; 59(6):606-13. PubMed ID: 15114301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis.
    Andriulli A; Leandro G; Federici T; Ippolito A; Forlano R; Iacobellis A; Annese V
    Gastrointest Endosc; 2007 Apr; 65(4):624-32. PubMed ID: 17383459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.
    Devière J; Le Moine O; Van Laethem JL; Eisendrath P; Ghilain A; Severs N; Cohard M
    Gastroenterology; 2001 Feb; 120(2):498-505. PubMed ID: 11159890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of daily oral prophylactic selenium treatment on the dibutyltin dichloride (DBTC)-induced pancreatitis in rats.
    Merkord J; Görl N; Lemke M; Berg A; Weber H; Ramer R; Hennighausen G
    EXCLI J; 2017; 16():89-100. PubMed ID: 28435430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
    Manes G; Ardizzone S; Lombardi G; Uomo G; Pieramico O; Porro GB
    Gastrointest Endosc; 2007 Jun; 65(7):982-7. PubMed ID: 17531632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study.
    Lee TY; Choi JS; Oh HC; Song TJ; Do JH; Cheon YK
    Korean J Intern Med; 2015 Sep; 30(5):602-9. PubMed ID: 26354054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
    Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
    Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Validity of aprotinin prophylaxis in pancreatitis complications following ERCP].
    Fiocca F; Schietroma M; Colella A; De Santis A; Stabile G; D'Ambrosio G; Greco E; Savino T; Fisicaro V; Pianese G
    G Chir; 1988 May; 9(5):357-8. PubMed ID: 2484805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.